Opioid Manufacturer Teva Pharmaceuticals Reaches $4B Global Settlement | Law.com
Teva Pharmaceuticals found liable in New York opioid trial - BBC News
Teva Pharmaceuticals: Israeli drugmaker to cut 14,000 jobs
Teva reaches proposed $4.35 billion settlement of US opioid lawsuits | CNN Business
Teva, Units Held Liable for Fueling N.Y. Opioid Crisis - Bloomberg
An Israeli pharma champion sickens
Teva Pharmaceuticals found liable for role in New York opioid epidemic - UPI.com
Israeli Pension Fund Manager Leads Class Action Against Teva Pharmaceuticals Over Price-Hike and Opioid Scandals | Courthouse News Service
These Israeli pharmaceutical stocks are down in the wake of Hamas attack - MarketWatch
Israel-based Teva settles opioid lawsuit with San Francisco for $45M
Teva Pharmaceuticals at heart of major price fixing suit in US – www.israelhayom.com
Teva Faces New Class Action—But Could It Afford Another Settlement? | Connecticut Law Tribune
Teva's Deal for Mylan Shows Corporate Israel's M&A Hunger - WSJ
Teva buys Allergan generic drug company for $40.5B - CBS News
Suffering from missteps, drugmaker Teva struggles to heal own ills | The Times of Israel
InnovationRx: Israel Makes Up 8% Of Teva's Global Production
Teva firing 350 employees from Israeli production facility | Ctech
A Drug Company Wagers the U.S. Won't Dare Charge It With Crimes - The New York Times
Teva reaches proposed $4.35 billion settlement of US opioid lawsuits | CNN Business
Drugmaker Teva does not see big impact on business from Israel-Hamas war | Reuters
Teva Eyes 25 Percent of the $750 Million EpiPen Market by Year's End | BioSpace
Israel's Teva to move US HQ from Pennsylvania to New Jersey | The Times of Israel
Teva Pharmaceuticals - Wikipedia
